Clinical trial
A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis
NCT02063672 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- March 31, 2019
- Enrollment
- 82 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
femoral artery occlusion, femoral artery stenosis, restenosis